Cadrenal Therapeutics, Inc.
CVKD
$5.17
-$0.02-0.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.01M | 3.86M | 5.57M | 7.34M | 10.02M |
| Total Receivables | 5.10K | 12.80K | 19.00K | 24.70K | 38.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 200.10K | 116.00K | 358.40K | 575.60K | 42.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 106.30K | 90.80K | 23.90K | 8.50K | 14.40K |
| Total Current Assets | 4.32M | 4.08M | 5.97M | 7.94M | 10.11M |
|
|
|||||
| Total Current Assets | 4.32M | 4.08M | 5.97M | 7.94M | 10.11M |
| Net Property, Plant & Equipment | 5.20K | 5.70K | 4.30K | 4.70K | 6.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.20K | 2.20K | 2.20K | 3.80K | 3.80K |
| Total Assets | 4.33M | 4.09M | 5.98M | 7.95M | 10.12M |
|
|
|||||
| Total Accounts Payable | 650.70K | 614.10K | 895.60K | 1.28M | 1.50M |
| Total Accrued Expenses | 937.30K | 738.50K | 783.90K | 561.80K | 1.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.59M | 1.35M | 1.68M | 1.84M | 2.68M |
|
|
|||||
| Total Current Liabilities | 1.59M | 1.35M | 1.68M | 1.84M | 2.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.59M | 1.35M | 1.68M | 1.84M | 2.68M |
|
|
|||||
| Common Stock & APIC | 41.70M | 38.66M | 37.53M | 35.68M | 33.16M |
| Retained Earnings | -38.96M | -35.92M | -33.24M | -29.57M | -25.72M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.74M | 2.73M | 4.30M | 6.11M | 7.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.74M | 2.73M | 4.30M | 6.11M | 7.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.74M | 2.73M | 4.30M | 6.11M | 7.44M |
|
|
|||||